The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Oseltamivir phosphate
Oseltamivir phosphate · OSELTAMIVIR PHOSPHATE 6 mg/mL · For Suspension · Oral · NuCare Pharmaceuticals, Inc.
NDC 68071-3960-06 · 1 POUCH in 1 CARTON / 1 BOTTLE in 1 POUCH / 60 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for oseltamivir phosphate (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- NuCare Pharmaceuticals,Inc.United Statesrelabel
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA212784
- TE code
- AB
- Approval date
- May 27, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Oseltamivir phosphate (For Suspension)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Preferred Pharmaceuticals Inc. | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Ajanta Pharma USA Inc. | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Inc. | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals NY LLC | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA, Inc | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Exelan Pharmaceuticals, Inc. | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals, Inc. | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Pharmaceuticals USA Inc. | OSELTAMIVIR PHOSPHATE 6 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Oseltamivir phosphate — NDC 68071-3960-06," retrieved September 3, 2026, https://drugdashboards.com/drug/68071396006.
Free to cite with attribution — see how the data is put together.